Industry News
A braking system for immune responses
Mar 24, 2014
For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune responses. The team, led by researchers from Technische Universität München (TUM)'s Klinikum rechts der Isar hospital have published their findings in the Immunity journal. Read More
More psychological support needed for breast cancer patients
Mar 24, 2014
For women who are suffering from breast cancer, concern for their children is the greatest source of worry. A researcher at The Sahlgrenska Academy has shown this, and believes that women who are at the earliest stage of the treatment should be offered support by a psychologist or a social worker.One out of every ten women in Sweden is affected by breast cancer at some time in her life. Read More
Breast cancer outcomes adversely affected by obesity and diabetes
Mar 24, 2014
Both obesity and diabetes have adverse effects on outcomes in breast cancer patients who receive chemotherapy as primary treatment before surgery (neoadjuvant chemotherapy), according to research presented at the 9th European Breast Cancer Conference (EBCC-9). Read More
Stem cells created from a drop of blood
Mar 24, 2014
Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed a method to generate human induced pluripotent stem cells (hiPSCs) from a single drop of finger-pricked blood. The method also enables donors to collect their own blood samples, which they can then send to a laboratory for further processing. Read More
Mood-stabilizing drug could reduce risk of head and neck cancer
Mar 24, 2014
New research suggests that a commonly used mood-stabilizing drug - valproic acid - could help reduce the risk of developing head and neck cancer.The research team, led by Dr. Johann Christoph Brandes of the Atlanta Veterans Medical Center and Emory University in Atlanta, GA, recently published their findings in the journal Cancer. Read More
Solving a longstanding mystery in cell division
Mar 24, 2014
The paradox of a cell that shuts down its DNA repair processes during cell division has been solved, according to research published in Science. The problem had eluded science for six decades."We now know why a crucial DNA-repair process shuts down just when the cell starts to divide into two daughter cells," says Dr. Read More
Genetic sources of disease pinpointed by new tool
Mar 24, 2014
Many diseases have their origins in either the genome or in reversible chemical changes to DNA known as the epigenome. Now, results of a new study from Johns Hopkins scientists show a connection between these two "maps. Read More
Results published from landmark study of immune response
Mar 24, 2014
Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., have announced that they have published an initial data analysis from the landmark Milieu Interieur Project in the journal Immunity, which provided new insights into the healthy human immune response. Read More
Chronic lymphocytic leukemia: Editorial published by North Shore-LIJ Cancer Institute doctors
Mar 23, 2014
Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the New England Journal of Medicine, the North Shore-LIJ Health System has announced.CLL is one of the most common forms of blood cancers, usually affecting those later in life. Read More
Study identifies gene fusion as likely cause of rare type of thyroid cancer
Mar 23, 2014
In a scientific first, the fusion of two genes, ALK and EML4, has been identified as the genetic driver in an aggressive type of thyroid cancer, according to a study by the Translational Genomics Research Institute (TGen). Read More
Previous Page Next Page